Get the Stockscreener App
10.43
2.61%
-0.28
Evolent Health Inc stock is traded at $10.43, with a volume of 5.20M.
It is down -2.61% in the last 24 hours and up +2.56% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
See More
Previous Close:
$10.71
Open:
$10.69
24h Volume:
5.20M
Relative Volume:
2.26
Market Cap:
$1.20B
Revenue:
$2.35B
Net Income/Loss:
$-74.42M
P/E Ratio:
-11.10
EPS:
-0.94
Net Cash Flow:
$150.93M
1W Performance:
+4.09%
1M Performance:
+2.56%
6M Performance:
-62.90%
1Y Performance:
-65.16%
1-Day Range:
$10.34
$11.03
1-Week Range:
$9.75
$11.03
52-Week Range:
$9.45
$35.00
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
800 NORTH GLEBE RD, SUITE 500, ARLINGTON
Compare EVH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
10.43 | 1.20B | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
225.79 | 36.66B | 2.66B | 665.91M | 1.08B | 4.05 |
|
DOCS
Doximity Inc
|
72.37 | 13.58B | 516.85M | 174.11M | 217.38M | 0.87 |
|
SOLV
Solventum Corp
|
73.02 | 12.61B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
TEM
Tempus Ai Inc
|
68.09 | 10.72B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
108.60 | 9.41B | 1.15B | 96.70M | -161.99M | 1.09 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Analysts Have Lowered Expectations For Evolent Health, Inc. (NYSE:EVH) After Its Latest Results - Simply Wall St
Evolent Health Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Evolent Health’s AI Strategy: Navigating Risks and Challenges Amidst Technological Advancements - TipRanks
Evolent Health Inc. Reports Mixed Earnings Results - TipRanks
Piper Sandler cuts Evolent Health target to $16, maintains overweight By Investing.com - Investing.com Canada
Evolent Health, Inc. SEC 10-K Report - TradingView
Evolent Health outlines 15%-18% growth target for 2025 amid oncology trend challenges - MSN
Evolent Health Inc (EVH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Oncology ... - Yahoo Finance
Evolent Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Evolent Health Reports Growth and Strategic Gains - TipRanks
Evolent Announces Fourth Quarter and Full Year 2024 Results - The Malaysian Reserve
Evolent Health: Q4 Earnings Snapshot - mySA
Evolent Health Inc earnings missed by $0.09, revenue fell short of estimates - Investing.com South Africa
Evolent Health (NYSE:EVH) Misses Q4 Sales Targets By Stock Story - Investing.com Canada
Evolent Health (EVH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Evolent Health Inc Reports Q4 EPS of -$0.27, Narrowly Beating Es - GuruFocus.com
Evolent Health (NYSE:EVH) Misses Q4 Sales Targets - Yahoo Finance
Evolent Health Swings to Q4 Adjusted Loss, Sales Rise; Revenue Guidance Set; Shares Drop After Hours - Marketscreener.com
Evolent Health (EVH) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Evolent Health (EVH) Q4 2024 Earnings Call Transcript - MSN
Evolent Health misses Q4 estimates, shares drop on weak guidance - Investing.com India
Evolent Health misses Q4 estimates, shares drop on weak guidance By Investing.com - Investing.com UK
Evolent Health, Inc. Reports Q4 and Full Year 2024 Financial Results - TradingView
Earnings Flash (EVH) Evolent Health Posts Q4 Revenue $646.5M, vs. FactSet Est of $651.3M - Marketscreener.com
Evolent Health Inc (EVH) Q4 2024 Earnings Report Preview: What T - GuruFocus.com
Evolent Health Inc (EVH) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Evolent Health (EVH) Q4 Earnings Report Preview: What To Look For - The Globe and Mail
Evolent Health (NYSE:EVH) Is Doing The Right Things To Multiply Its Share Price - Yahoo Canada Finance
Evolent Health's SWOT analysis: stock faces challenges amid growth potential By Investing.com - Investing.com Nigeria
Evolent Health's SWOT analysis: stock faces challenges amid growth potential - Investing.com
Canaccord cuts Evolent Health target to $16, maintains Buy - MSN
Evolent Health (EVH) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance
(EVH) Technical Data - Stock Traders Daily
Evolent Health, Inc. (NYSE:EVH) Shares Purchased by Entropy Technologies LP - MarketBeat
Evolent Health (NYSE:EVH) Given Market Outperform Rating at JMP Securities - MarketBeat
Needham & Company LLC Reaffirms Buy Rating for Evolent Health (NYSE:EVH) - MarketBeat
Evolent Health (NYSE:EVH) Hits New 1-Year LowTime to Sell? - MarketBeat
Evolent Health stock hits 52-week low at $9.55 - MSN
Earnings Preview: Evolent Health (EVH) Q4 Earnings Expected to Decline - Yahoo Finance
Evolent Health stock hits 52-week low at $9.55 By Investing.com - Investing.com Canada
Evolent Health Stock: A Deep Dive Into Analyst Perspectives (15 Ratings) - Benzinga
Evolent Health (NYSE:EVH) Hits New 52-Week LowWhat's Next? - MarketBeat
Further weakness as Evolent Health (NYSE:EVH) drops 7.5% this week, taking one-year losses to 68% - Simply Wall St
Evolent Health gains as activist Engaged Capital reaches cooperation agreement - MSN
William Blair Lowers Earnings Estimates for Evolent Health - MarketBeat
How the (EVH) price action is used to our Advantage - Stock Traders Daily
Evolent Health appoints new chair and independent director By Investing.com - Investing.com South Africa
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
9.30%
2.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):